Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Change in Acquisitions & Divestments: 2015-2020

Historic Change in Acquisitions & Divestments for Larimar Therapeutics (LRMR) over the last 5 years, with Mar 2020 value amounting to $20.5 million.

  • Larimar Therapeutics' Change in Acquisitions & Divestments fell 40.10% to $20.5 million in Q1 2020 from the same period last year, while for Mar 2020 it was $95.7 million, marking a year-over-year decrease of 15.90%. This contributed to the annual value of $143.0 million for FY2024, which is 6.12% up from last year.
  • As of Q1 2020, Larimar Therapeutics' Change in Acquisitions & Divestments stood at $20.5 million, which was up 171.91% from $7.6 million recorded in Q4 2019.
  • Larimar Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $52.7 million for Q3 2016, and its period low was $7.6 million during Q4 2019.
  • For the 3-year period, Larimar Therapeutics' Change in Acquisitions & Divestments averaged around $26.7 million, with its median value being $25.9 million (2019).
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first spiked by 67.98% in 2016, then slumped by 70.33% in 2019.
  • Over the past 5 years, Larimar Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $47.2 million in 2016, then dropped by 19.45% to $38.0 million in 2017, then crashed by 33.11% to $25.4 million in 2018, then plummeted by 70.33% to $7.6 million in 2019, then tumbled by 40.10% to $20.5 million in 2020.
  • Its last three reported values are $20.5 million in Q1 2020, $7.6 million for Q4 2019, and $25.9 million during Q3 2019.